The Value of the 8th Edition of American Joint Committee on Cancer Pathological Prognostic Staging on the Selection of Postmastectomy Radiotherapy for T1–2N1 Breast Cancer

Figure 3

Time-dependent receiver operating characteristics analyses for assessing the discriminative value of breast cancer-specific survival between the 7th and 8th AJCC staging systems (predicted time: 164 months).